1. Response to letter regarding “Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure”
   Rui-Jie Gao et al, 2015, International Journal of Cardiology CrossRef
2. Simvastatin protects the heart against ischemia reperfusion injury via inhibiting HMGB1 expression through PI3K/Akt signal pathways
   Qian-Feng Han et al, 2015, International Journal of Cardiology CrossRef
3. HMGB1 promotes HLF-1 proliferation and ECM production through activating HIF1-α-regulated aerobic glycolysis
   JianNing Xu et al, 2017, Pulmonary Pharmacology & Therapeutics CrossRef
4. miR-129-5p improves cardiac function in rats with chronic heart failure through targeting HMGB1
   Na Xiao et al, 2019, Mamm Genome CrossRef
5. HMGB1 Protects the Heart Against Ischemia–Reperfusion Injury via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression
   Yan-Hong Zhou et al, 2020, Front. Physiol. CrossRef
6. PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review)
   Zhen Zhang et al, 2018, Mol Med Report CrossRef
7. Isoflurane reduces pain and inhibits apoptosis of myocardial cells through the phosphoinositide 3-kinase/protein kinase�B signaling pathway in mice during cardiac surgery
   Zhibing Pi et al, 2018, Mol Med Report CrossRef
8. Tazarotene gel promotes healing of deep tissue injury in mice
   P. P. Liu et al, 2021, Biotechnic & Histochemistry CrossRef
9. MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis
   Jinxue Liu et al, 2021, Disease Markers CrossRef
10. Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
    Peng Zhou et al, 2021, J Gastric Cancer CrossRef
11. Atractylenolide-1 Targets FLT3 to Regulate PI3K/AKT/HIF1-α Pathway to Inhibit Osteogenic Differentiation of Human Valve Interstitial Cells
    Jie Wang et al, 2022, Front. Pharmacol. CrossRef